1Nixon AJ.Brower Toland BD.Sandell LJ.Primary nucleotide structure of predominant and alternate splice forms of equine insulin-like growth factor 1 and their gene expression patterns in tissue[J].Am J Vet Res,1999,60:1234
2Clemmons DR,Moses A C,Mckav M J,et al.The combination of insulin-like growth factor 1 and insulin-like growth factor binding protein-3 reduces insulin requirement in insulin-dependent type 1 diabetes:evidence for in vivo biological activity[J].J Clin Endocrinol Metab,2000,85:1518
3Klinger B,Anin S,Silbergeld A,et al.Development of hyperandrogenism during treatment with insulin-like growth factor-1(IGF-1 in female patient with Laron svndrome[J].Clin Endocrinol(0xf),1998,48(1):81-87
4Kowalska I,Kinalski M,Straczkowski M,et al.Insulin,leptin,IGF-1 and insulin-dependent protein concentrations after insulin-sensitizing therapy in obese women with polycystic ovary syndrome[J].Eur J Endocrinol,2001,144(5):509-515
5Van Dam EW,Roellsema F,Helmerhorst FH,et al.Low amplitude and disorderly spontaneous growth hormone release in obese women with or without polycystic ovary syndrome[J].J Clin Endocrinol Metab,2002,87 (9):4225-4230
6Amin AF,Abd el-Aal DE,Darwish AM,et al.Evaluation of the impact of laparoscopic ovarian drilling on Doppler indices of ovarian stromal blood flow,serum vascular endothelial growth factor,and insulin-like growth factor-1 in women with polycystic ovary syndrome[J].Fertil Steri1,2003,79(4):938-941
7Shobokshi A,Shaarawy M.Correction of insulin resistance and hyperandrogenism in polycystic ovary syrrdrotrre by combined tusiglitazone and clomiphene citrate therapy[J].J Soc Gynecol Investig,2003,10(2):99-104
3Roberts VJ, Barth S, El - Roeiy A, et al. Expression of inhibin/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome. J Clin Endocrinol Metab, 1994, 79: 1434- 1439.
4Lu C, Yang W, Chen M, et al. Inhibin A inhibits follicle- stimulating hormone (FSH) action by suppressing its receptor expression in cultured rat granulosa cells. Mol Cell Endocrinol, 2009, 298: 48-56.
5Norman RJ, Milner CR, Groome NP, et al. Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome. Hum Reprod, 2001, 16: 668-672.
6Lerch TF, Shimasaki S, Woodruff TK, et al. Structural and biophysical coupling of heparin and activin binding to follistatin isoform functions. J Biol Chem, 2007, 282: 15930 - 15939.
7Schmierer B, Schuster MK, Shkumatava A, et al. Activin and follicle- stimulating hormone signaling are required for long - term culture of functionally differentiated primary granulosa cells from the chicken ovary. Bioi Reprod, 2003, 68.. 620- 627.
8Pang Y, Ge W. Gonadotropin and activin enhance maturational competence of oocytes in the zebrafish ( Dnio rerio). Biol Reprod, 2002, 66: 259-265.
9Amaxo G, Izzo A, Tucker A, et al. Insulin- like growth factor binding protein - 3 reduction in follicular fluid in spontaneous and stimulated cycles. Fertil Steril, 1998, 70:141 - 144.
10Rivera GM, Fortune JE. Selection of the dominant follicle and insulin -like growth factor (IGF) -binding proteins: evidence that pregnancy-associated plasma protein A contributes to proteolysis of IGF - binding protein 5 in bovine follicular fluid. Endocrinology, 2003, 144: 437 - 446.
